Skip to main content
logo
Eli Lilly and Company (VIE:LLYC)
Austria flag Austria · Delayed Price · Currency is EUR
836.90
-24.40 (-2.83%)
At close: Mar 5, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Baqsimi Revenue
-29.10M
Baqsimi Revenue Growth
--95.70%
Basaglar Revenue
626.00M676.90M
Basaglar Revenue Growth
-7.52%-7.06%
Humalog Revenue
2.17B2.32B
Humalog Revenue Growth
-6.74%39.77%
Humulin Revenue
705.00M917.10M
Humulin Revenue Growth
-23.13%7.63%
Jardiance Revenue
3.43B3.34B
Jardiance Revenue Growth
2.73%21.72%
Mounjaro Revenue
22.97B11.54B
Mounjaro Revenue Growth
99.00%123.51%
Trajenta Revenue
318.00M353.90M
Trajenta Revenue Growth
-10.14%-8.53%
Trulicity Revenue
4.28B5.25B
Trulicity Revenue Growth
-18.61%-26.35%
Zepbound Revenue
13.54B4.93B
Zepbound Revenue Growth
174.93%2701.88%
Other Cardiometabolic Health Revenue
189.00M187.90M
Other Cardiometabolic Health Revenue Growth
0.58%31.31%
Cardiometabolic Health Revenue
48.22B29.52B
Cardiometabolic Health Revenue Growth
63.34%50.10%
Oncology Revenue
9.38B8.75B
Oncology Revenue Growth
7.12%31.45%
Immunology Revenue
5.25B4.39B
Immunology Revenue Growth
19.44%15.68%
Neuroscience Revenue
1.39B1.47B
Neuroscience Revenue Growth
-5.59%-48.81%
Other Product Revenue
944.00M903.00M
Other Product Revenue Growth
4.54%-19.53%
Revenue (Other)
-400.00K
Revenue (Total)
65.18B45.04B
Revenue (Total) Growth
44.70%32.00%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
US Revenue
43.48B30.38B
US Revenue Growth
43.15%39.39%
Europe Revenue
11.56B6.92B
Europe Revenue Growth
67.01%12.08%
Japan Revenue
2.13B1.81B
Japan Revenue Growth
17.47%8.51%
China Revenue
1.95B1.66B
China Revenue Growth
17.50%7.84%
Other Foreign Countries Revenue
6.06B4.27B
Other Foreign Countries Revenue Growth
41.80%44.98%
Revenue (Other)
-400.00K
Revenue (Total)
65.18B45.04B
Revenue (Total) Growth
44.70%32.00%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Revenue Change due to Price
-6.00%5.00%
Revenue Change due to Volume
50.00%27.00%
Revenue Change due to FX
1.00%-
Updated Dec 31, 2025. Data Source: Fiscal.ai.